NGS Informatics Market – A Global and Regional Analysis: Focus on Products and Services, Application, End User, and Region – Analysis and Forecast, 2022-2032

$5,250$8,100

The global NGS informatics market was valued at $1,380.0 million in 2021 and is projected to reach $6,715.0 million by the end of 2032. The market is expected to grow at a CAGR of 15.21% during the forecast period 2022-2032.

SKU: BHP0641SB Category: Tag:

Description

Global NGS Informatics Market Industry Overview

The global NGS informatics market was valued at $1,380.0 million in 2021 and is projected to reach $6,715.0 million by the end of 2032. The market is expected to grow at a CAGR of 15.21% during the forecast period 2022-2032. The market is driven by factors such as the low cost of sequencing platforms, increasing clinical applications of NGS in the field of oncology for the clinical management of cancer patients and mutation profiling, a tremendous rise in the amount of genomic data, the growing importance of population genomics studies and the establishment of various biobanks, advancements in big data technology, and government initiatives to support the advancement of NGS are expected to lead to higher demand for NGS informatics software.

Market Lifecycle Stage

The global NGS informatics market is in the development phase. The evolving regulatory landscape for clinical NGS and the growing number of gene mutations across various diseases are some of the major opportunities in the global NGS informatics market.

Impact of COVID-19

NGS can be used to sequence genomes of unknown organisms, owing to which it was extensively performed in research laboratories during the COVID-19 pandemic. Research using NGS sequencing has been carried out in several countries globally, including countries in emerging regions such as Latin America and Middle East and Africa. Initiatives such as the “SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology, and Surveillance (SPHERES)” program by the Centers for Disease Control and Prevention (CDC) were also undertaken to promote the sequencing of the SARS-CoV-2 virus using NGS techniques. Furthermore, the emergence of the COVID-19 pandemic broadened the applications of NGS. As a result, companies also developed NGS solutions for the genomic surveillance of the SARS-CoV-2 virus. Before the COVID-19 pandemic, NGS technology was particularly employed for the clinical diagnosis of cancers and other chronic diseases. The onset of the COVID-19 pandemic accelerated research in the use of NGS for sequencing the unknown variants of the SARS-CoV-2 virus.

Market Segmentation:

Segmentation 1: by Products and Services

• Commercial Data Analysis, Data Interpretation, and Reporting Tools
• Storage and Computing Tools
Laboratory Information Management Systems (LIMS)
• NGS Informatics Services

The global NGS informatics market (by products and services) is expected to be dominated by the commercial data analysis tools, interpretation, and reporting tools segment.

Segmentation 2: by Application

• Drug Discovery
• Genetic Screening
• Disease Diagnosis
• Others

The global NGS informatics market (by application) is expected to be dominated by the genetic screening segment.

Segmentation 3: by End User

• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutions

The global NGS informatics market (by end user) is dominated by the pharmaceutical and biotechnology companies segment.

Segmentation 4: by Region

• North America – U.S. and Canada
• Europe – Germany, France, U.K., Italy, Spain, and Rest-of-Europe
• Asia-Pacific – Japan, China, India, Australia, South Korea, and Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, and Rest-of-Latin America
• Rest-of-the-World

The global NGS informatics market (by region) is dominated by the North America region.

Recent Developments in the Global NGS Informatics Market

• In August 2022, Thermo Fisher Scientific Inc. launched CE-IVD (IVDD) NGS test and analysis software to expand access to precision oncology bio-market testing.
• In June 2022, Thermo Fisher Scientific received CE-IVD Mark for NGS Aneuploidy Diagnostic Software Workflow.
• In April 2021, Agilent acquired Resolution Bioscience to expand its role in the NGS market for precision oncology.
• In June 2020, Illumina acquired BlueBee to accelerate the processing, analysis, and sharing of NGS data at scale. The integration of BlueBee’s capabilities into Illumina’s cloud portfolio would give users the flexibility to run their own custom analyses or access industry-leading options such as the DRAGEN Bio-IT Platform, streamlining data processing and increasing their operational efficiency.
• In July 2021, Francisco Partners signed a definitive agreement to acquire the STARLIMS informatics product suite and related businesses.
• In April 2021, Illumina Inc. and Kartos Therapeutics entered into a partnership to co-develop an NGS-Based TP53 companion diagnostic based on Illumina’s genomic profiling assay.

Demand – Drivers and Limitations

The following are the drivers for the global NGS informatics market:

• The low cost of sequencing platforms is increasing public access to NGS testing, thereby improving the adoption of NGS informatics solutions.
• Increasing clinical applications of NGS in the field of oncology for the clinical management of cancer patients and mutation profiling to identify subsequent treatment options is fueling the demand for NGS.
• A tremendous rise in the amount of genomic data is driving the adoption of NGS informatics solutions for easy analysis of data as well as for its storage and computation.
• The growing importance of population genomics studies and the establishment of various biobanks lead to extensive research throughout the world and help in advancing research and development in the genomics field.
• Advancements in big data technology will enable better storage and management of NGS data, thereby leading to more demand for NGS and higher adoption of NGS software.
• Government initiatives to support the advancement of NGS are expected to lead to higher demand for NGS informatics software.

The market is expected to face some limitations as well due to the following challenges:

• Privacy and ethical challenges are expected to lead to concerns surrounding data privacy among people, thereby hindering their participation in NGS studies.
• The lack of trained clinical personnel for conducting NGS experiments and performing data analysis is expected to hinder the adoption of NGS software.
• Poor reimbursement rates for NGS across the globe are expected to lead to a lack of interest in NGS, thereby hindering the adoption of NGS software and services.

How can this report add value to an organization?

Products and Services: The products and services segment helps the reader understand the different types of NGS informatics products and services available in the market. Moreover, the study provides the reader with a detailed understanding of products that fall under the main segments, such as commercial data analysis, data interpretation and reporting tools, storage and computing tools, laboratory information management systems (LIMS), and NGS informatics services.

Growth/Marketing Strategy: The global NGS informatics market has witnessed major development by key players operating in the market, such as product launches, business expansions, partnerships, collaborations, mergers and acquisitions, funding activities, and regulatory and legal approvals. The favored strategy for the companies has been business expansions, partnerships, and collaborations to strengthen their position in the market. For instance, in July 2021, Francisco Partners signed a definitive agreement to acquire the STARLIMS informatics product suite and related businesses.

Competitive Strategy: The key players in the global NGS informatics market analyzed and profiled in the study involve established and emerging players that offer different products for NGS informatics. Moreover, a detailed competitive benchmarking of the players operating in the global NGS informatics market has been done to help the reader understand the ways in which players stack against each other, presenting a clear market landscape. Moreover, comprehensive competitive strategies such as partnerships, agreements, collaborations, mergers, and acquisitions will help the reader understand the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent established names in this market are:

• Abbott Laboratories
• Agilent Technologies, Inc.
• Azenta, Inc.
• BGI Genomics Co., Ltd.
• DNAnexus, Inc.
• Eagle Genomics
• Euformatics
• F. Hoffmann-La Roche Ltd.
• Genalice BV
• Illumina, Inc.
• Partek Incorporated
• PerkinElmer, Inc.
• Precigen, Inc.
• QIAGEN N.V.
• SOPHiA GENETICS SA
• Thermo Fisher Scientific Inc.

Companies that are not a part of the aforementioned pool have been well represented across different sections of the report (wherever applicable).

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Base Year

2022

Base Market Size

$1, 630.5 Million in 2022

Currency

USD

Forecast Year

2032

Market Size Forecast

$6, 715.0 Million by 2032

CAGR

15.21%

Table of Contents

1 Markets
1.1 Global Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.1.3 Key Findings
1.1.4 Assumptions and Limitations
1.2 Industry Outlook
1.2.1 Market Overview
1.2.1.1 Introduction
1.2.1.2 Evolution of NGS Technology
1.2.1.3 Workflow for NGS Informatics Market
1.2.1.4 Market Future Potential
1.2.2 Legal Requirements and Framework
1.2.2.1 Legal Requirements and Framework in the U.S.
1.2.2.1.1 U.S. Food and Drug Administration (FDA)
1.2.2.2 Legal Requirements and Framework in Europe
1.2.2.2.1 European Medicines Agency (EMA)
1.2.2.3 Legal Requirements and Framework in Asia-Pacific
1.2.2.3.1 China
1.2.2.3.1.1 National Medical Products Administration (NMPA)
1.2.2.3.2 Japan
1.2.2.3.2.1 Pharmaceuticals and Medical Devices Agency (PMDA)
1.2.3 Key Trends
1.2.3.1 Growing Adoption of Cloud-Based Solutions to Enable Easy Storage of the Large Amounts of NGS Data
1.2.3.2 Growing Automation of Sample/Library Preparation of the NGS Workflow Using NGS Informatics
1.2.3.3 Increasing Use of NGS in Clinical Trials to Select the Right Candidates
1.2.3.4 Significantly Higher Representation of European Candidates in Large-Scale Genomic Research Studies
1.2.4 Opportunity Assessment
1.2.5 Costs of Storage of NGS Data on Cloud
1.2.6 Product Benchmarking
1.2.7 Patent Analysis
1.2.7.1 Awaited Technological Developments
1.2.7.2 Patent Filing Trend (by Year)
1.2.7.3 Patent Filing Trend (by Region)
1.2.7.4 Patent Filing Trend (by Country)
1.2.8 Market Value Chain
1.3 Impact of COVID-19 on the Global NGS Informatics Market
1.3.1 Impact on NGS Research Related to the SARS-CoV-2 Virus
1.3.2 Impact on New Product Launches by Market Players
1.3.3 Comparison of Pre, During, and Post-COVID-19 Scenarios
1.4 Business Dynamics
1.4.1 Impact Analysis
1.4.2 Business Drivers
1.4.2.1 Low cost of sequencing platforms is increasing public access to NGS testing and thus improving the adoption of NGS informatics solutions.
1.4.2.2 Increasing clinical applications of NGS in the field of oncology for the clinical management of cancer patients and mutation profiling to identify subsequent treatment options is increasing the demand for NGS.
1.4.2.3 Tremendous rise in the amount of genomic data is driving the adoption of NGS informatics solutions for easy analysis of data as well as for its storage and computation.
1.4.2.4 Growing importance of population genomics studies and the establishment of various biobanks lead to extensive research throughout the world and help in advancing research and development in the genomics field.
1.4.2.5 Advancements in big data technology will enable better storage and management of NGS data, thus leading to more demand for NGS and higher adoption of NGS software.
1.4.2.6 Government initiatives to support the advancement of NGS are expected to lead to higher demand for NGS informatics software.
1.4.3 Business Restraints
1.4.3.1 Privacy challenges are expected to lead to concerns surrounding data privacy among people and thus hinder their participation in NGS studies.
1.4.3.2 Lack of trained clinical personnel for conducting NGS experiments and performing data analysis is expected to hinder the adoption of NGS software.
1.4.3.3 Poor reimbursement rates for NGS across the globe are expected to lead to a lack of interest in NGS and thus hinder the adoption of NGS software and services.
1.4.4 Business Opportunities
1.4.4.1 Evolving Regulatory Landscape for Clinical NGS
1.4.4.2 Growing Number of Gene Mutations across Various Diseases
2 Global NGS Informatics Market (by Products and Services)
2.1 Opportunity Assessment
2.2 Commercial Data Analysis, Data Interpretation, and Reporting Tools
2.3 Storage and Computing Tools
2.4 Laboratory Information Management Systems (LIMS)
2.5 NGS Informatics Services
3 Global NGS Informatics Market (by Application)
3.1 Opportunity Assessment
3.2 Drug Discovery
3.3 Genetic Screening
3.4 Disease Diagnosis
3.5 Others
4 Global NGS Informatics Market (by End User)
4.1 Opportunity Assessment
4.2 Hospitals and Clinics
4.3 Pharmaceutical and Biotechnology Companies
4.4 Academic and Research Institutions
5 Region
5.1 North America
5.1.1 Key Findings and Opportunity Assessment
5.1.2 Market Dynamics
5.1.2.1 Impact Analysis
5.1.3 Sizing and Forecast Analysis
5.1.3.1 North America NGS Informatics Market (by End User)
5.1.3.2 North America NGS Informatics Market (by Country)
5.1.3.2.1 U.S.
5.1.3.2.1.1 Market Dynamics
5.1.3.2.1.2 Market Sizing and Forecast
5.1.3.2.1.2.1 U.S. NGS Informatics Market (by End User)
5.1.3.2.2 Canada
5.1.3.2.2.1 Market Dynamics
5.1.3.2.2.2 Market Sizing and Forecast
5.1.3.2.2.2.1 Canada NGS Informatics Market (by End User)
5.2 Europe
5.2.1 Key Findings and Opportunity Assessment
5.2.2 Market Dynamics
5.2.2.1 Impact Analysis
5.2.3 Sizing and Forecast Analysis
5.2.3.1 Europe NGS Informatics Market (by End User)
5.2.3.2 Europe NGS Informatics Market (by Country)
5.2.3.2.1 Germany
5.2.3.2.1.1 Market Dynamics
5.2.3.2.1.2 Market Sizing and Forecast
5.2.3.2.1.2.1 Germany NGS Informatics Market (by End User)
5.2.3.2.2 France
5.2.3.2.2.1 Market Dynamics
5.2.3.2.2.2 Market Sizing and Forecast
5.2.3.2.2.2.1 France NGS Informatics Market (by End User)
5.2.3.2.3 U.K.
5.2.3.2.3.1 Market Dynamics
5.2.3.2.3.2 Market Sizing and Forecast
5.2.3.2.3.2.1 U.K. NGS Informatics Market (by End User)
5.2.3.2.4 Italy
5.2.3.2.4.1 Market Dynamics
5.2.3.2.4.2 Market Sizing and Forecast
5.2.3.2.4.2.1 Italy NGS Informatics Market (by End User)
5.2.3.2.5 Spain
5.2.3.2.5.1 Market Dynamics
5.2.3.2.5.2 Market Sizing and Forecast
5.2.3.2.5.2.1 Spain NGS Informatics Market (by End User)
5.2.3.2.6 Rest-of-Europe
5.2.3.2.6.1 Market Dynamics
5.2.3.2.6.2 Market Sizing and Forecast
5.2.3.2.6.2.1 Rest-of-Europe NGS Informatics Market (by End User)
5.3 Asia-Pacific
5.3.1 Key Findings and Opportunity Assessment
5.3.2 Market Dynamics
5.3.2.1 Impact Analysis
5.3.3 Sizing and Forecast Analysis
5.3.3.1 Asia-Pacific NGS Informatics Market (by End User)
5.3.3.2 Asia-Pacific NGS Informatics Market (by Country)
5.3.3.2.1 China
5.3.3.2.1.1 Market Dynamics
5.3.3.2.1.2 Market Sizing and Forecast
5.3.3.2.1.2.1 China NGS Informatics Market (by End User)
5.3.3.2.2 Japan
5.3.3.2.2.1 Market Dynamics
5.3.3.2.2.2 Market Sizing and Forecast
5.3.3.2.2.2.1 Japan NGS Informatics Market (by End User)
5.3.3.2.3 India
5.3.3.2.3.1 Market Dynamics
5.3.3.2.3.2 Market Sizing and Forecast
5.3.3.2.3.2.1 India NGS Informatics Market (by End User)
5.3.3.2.4 Australia
5.3.3.2.4.1 Market Dynamics
5.3.3.2.4.2 Market Sizing and Forecast
5.3.3.2.4.2.1 Australia NGS Informatics Market (by End User)
5.3.3.2.5 South Korea
5.3.3.2.5.1 Market Dynamics
5.3.3.2.5.2 Market Sizing and Forecast
5.3.3.2.5.2.1 South Korea NGS Informatics Market (by End User)
5.3.3.2.6 Rest-of-Asia-Pacific
5.3.3.2.6.1 Market Dynamics
5.3.3.2.6.2 Market Sizing and Forecast
5.3.3.2.6.2.1 Rest-of-Asia-Pacific NGS Informatics Market (by End User)
5.4 Latin America
5.4.1 Key Findings and Opportunity Assessment
5.4.2 Market Dynamics
5.4.2.1 Impact Analysis
5.4.3 Sizing and Forecast Analysis
5.4.3.1 Latin America NGS Informatics Market (by End User)
5.4.3.2 Latin America NGS Informatics Market (by Country)
5.4.3.2.1 Brazil
5.4.3.2.1.1 Market Dynamics
5.4.3.2.1.2 Market Sizing and Forecast
5.4.3.2.1.2.1 Brazil NGS Informatics Market (by End User)
5.4.3.2.2 Mexico
5.4.3.2.2.1 Market Dynamics
5.4.3.2.2.2 Market Sizing and Forecast
5.4.3.2.2.2.1 Mexico NGS Informatics Market (by End User)
5.4.3.2.3 Rest-of-Latin America
5.4.3.2.3.1 Market Dynamics
5.4.3.2.3.2 Market Sizing and Forecast
5.4.3.2.3.2.1 Rest-of-Latin America NGS Informatics Market (by End User)
5.5 Rest-of-the-World
5.5.1 Key Findings and Opportunity Assessment
5.5.2 Market Dynamics
5.5.2.1 Impact Analysis
5.5.3 Sizing and Forecast Analysis
5.5.3.1 Rest-of-the-World NGS Informatics Market (by End User)
6 Markets- Competitive Benchmarking and Company Profiles
6.1 Competitive Benchmarking
6.1.1 Key Strategies and Developments
6.1.1.1.1 New Offerings
6.1.1.1.2 Mergers and Acquisitions
6.1.1.1.3 Partnerships, Alliances, and Business Expansions
6.1.1.1.4 Regulatory and Legal Activities
6.1.1.1.5 Funding Activities
6.1.2 Market Share Analysis
6.1.3 Growth Share Analysis
6.1.3.1 Growth-Share Matrix (by Products and Services)
6.1.3.2 Growth-Share Matrix (by Application)
6.1.3.3 Growth-Share Matrix (by End User)
6.2 Company Profile
6.2.1 Abbott Laboratories
6.2.1.1 Company Overview
6.2.1.2 Role of Abbott Laboratories in the Global NGS Informatics Market
6.2.1.3 Financials
6.2.1.4 Key Customers
6.2.1.5 Recent Developments
6.2.1.6 Analyst Perception
6.2.2 Agilent Technologies, Inc.
6.2.2.1 Company Overview
6.2.2.2 Role of Agilent Technologies, Inc. in the Global NGS Informatics Market
6.2.2.3 Financials
6.2.2.4 Key Customers
6.2.2.5 Recent Developments
6.2.2.6 Analyst Perception
6.2.3 Azenta, Inc.
6.2.3.1 Company Overview
6.2.3.2 Role of Azenta, Inc. in the Global NGS Informatics Market
6.2.3.3 Financials
6.2.3.4 Key Customers
6.2.3.5 Recent Developments
6.2.3.6 Analyst Perception
6.2.4 BGI Genomics Co., Ltd.
6.2.4.1 Company Overview
6.2.4.2 Role of BGI Genomics Co., Ltd. in the Global NGS Informatics Market
6.2.4.3 Financials
6.2.4.4 Key Customers
6.2.4.5 Recent Developments
6.2.4.6 Analyst Perception
6.2.5 DNAnexus, Inc.
6.2.5.1 Company Overview
6.2.5.2 Role of DNAnexus, Inc. in the Global NGS Informatics Market
6.2.5.3 Key Customers
6.2.5.4 Recent Developments
6.2.5.5 Analyst Perception
6.2.6 Eagle Genomics
6.2.6.1 Company Overview
6.2.6.2 Role of Eagle Genomics in the Global NGS Informatics Market
6.2.6.3 Key Customers
6.2.6.4 Analyst Perception
6.2.7 Euformatics
6.2.7.1 Company Overview
6.2.7.2 Role of Euformatics in the Global NGS Informatics Market
6.2.7.3 Key Customers
6.2.7.4 Analyst Perception
6.2.8 F. Hoffmann-La Roche Ltd.
6.2.8.1 Company Overview
6.2.8.2 Role of F. Hoffmann-La Roche Ltd. in the Global NGS Informatics Market
6.2.8.3 Financials
6.2.8.4 Key Customers
6.2.8.5 Analyst Perception
6.2.9 Genalice BV
6.2.9.1 Company Overview
6.2.9.2 Role of Genalice BV in the Global NGS Informatics Market
6.2.9.3 Key Customers
6.2.9.4 Analyst Perception
6.2.10 Illumina, Inc.
6.2.10.1 Company Overview
6.2.10.2 Role of Illumina, Inc. in the Global NGS Informatics Market
6.2.10.3 Financials
6.2.10.4 Key Customers
6.2.10.5 Recent Developments
6.2.10.6 Analyst Perception
6.2.11 Partek Incorporated
6.2.11.1 Company Overview
6.2.11.2 Role of Partek Incorporated in the Global NGS Informatics Market
6.2.11.3 Key Customers
6.2.11.4 Recent Developments
6.2.11.5 Analyst Perception
6.2.12 PerkinElmer, Inc.
6.2.12.1 Company Overview
6.2.12.2 Role of PerkinElmer, Inc. in the Global NGS Informatics Market
6.2.12.3 Financials
6.2.12.4 Key Customers
6.2.12.5 Analyst Perception
6.2.13 Precigen, Inc.
6.2.13.1 Company Overview
6.2.13.2 Role of Precigen, Inc. in the Global NGS Informatics Market
6.2.13.3 Financials
6.2.13.4 Key Customers
6.2.13.5 Recent Developments
6.2.13.6 Analyst Perception
6.2.14 QIAGEN N.V.
6.2.14.1 Company Overview
6.2.14.2 Role of QIAGEN N.V. in the Global NGS Informatics Market
6.2.14.3 Financials
6.2.14.4 Key Customers
6.2.14.5 Recent Developments
6.2.14.6 Analyst Perception
6.2.15 SOPHiA GENETICS SA
6.2.15.1 Company Overview
6.2.15.2 Role of SOPHiA GENETICS SA in the Global NGS Informatics Market
6.2.15.3 Financials
6.2.15.4 Key Customers
6.2.15.5 Recent Developments
6.2.15.6 Analyst Perception
6.2.16 Thermo Fisher Scientific Inc.
6.2.16.1 Company Overview
6.2.16.2 Role of Thermo Fisher Scientific Inc. in the Global NGS Informatics Market
6.2.16.3 Financials
6.2.16.4 Key Customers
6.2.16.5 Recent Developments
6.2.16.6 Analyst Perception
List of Figures
Figure 1: Global NGS Informatics Market, Different Types of Cloud Services for Storage and Computation of NGS Data
Figure 2: Global NGS Informatics Market, Impact Analysis
Figure 3: Global NGS Informatics Market (by Products and Services), Share (%), 2021 and 2032
Figure 4: Global NGS Informatics Market (by Application), Share (%), 2021 and 2032
Figure 5: Global NGS Informatics Market (by Region), $Million, 2022 and 2032
Figure 6: Global NGS Informatics Market: Research Methodology
Figure 7: Primary Research Sources
Figure 8: Secondary Research
Figure 9: Data Triangulation
Figure 10: Global NGS Informatics Market, Research Process
Figure 11: Assumptions and Limitations
Figure 12: Global NGS Informatics Market Segmentation
Figure 13: Global NGS Informatics Market, Different Generations of Sequencing Technologies
Figure 14: Global NGS Informatics Market, Key Landmarks in NGS Evolution
Figure 15: Global NGS Informatics Market, Different Types of Cloud Services for Storage and Computation of NGS Data
Figure 16: Global NGS Informatics Market, Automation in Key Processes of an NGS Workflow
Figure 17: Global NGS Informatics Market Key Trends, Market Shift, 2022-2032
Figure 18: Global NGS Informatics Market, Factors Contributing to the Cost of Storage of NGS Data on the Cloud
Figure 19: Global NGS Informatics Market, Patent Analysis (by Year), January 2018-November 2022
Figure 20: Global NGS Informatics Market, Patent Analysis (by Country), January 2018-November 2022
Figure 21: Global NGS Informatics Market, Patent Analysis (by Country), January 2018-November 2022
Figure 22: Global NGS Informatics Market, Pre, During, and Post-COVID-19 Comparison
Figure 23: Global NGS Informatics Market, Impact Analysis
Figure 24: Global NGS Informatics Market, Key High-Performance Computing Systems and their Applications in NGS
Figure 25: Global NGS Informatics Market, Share of Global Genomic Initiatives in Different Regions
Figure 26: Global NGS Informatics Market, Genome Sequencing Initiatives in Europe
Figure 27: Global NGS Informatics Market (by Products and Services)
Figure 28: Global NGS Informatics Market, Incremental Opportunity (by Products and Services), $Million, 2022-2032
Figure 29: Global NGS Informatics Market (Commercial Data Analysis, Data Interpretation, and Reporting Tools), $Million, 2021-2032
Figure 30: Global NGS Informatics Market (Storage and Computing Tools), $Million, 2021-2032
Figure 31: Global NGS Informatics Market, Key Factors to be Considered When Selecting an LIMS for an NGS Laboratory
Figure 32: Global NGS Informatics Market (Laboratory Information Management Systems), $Million, 2021-2032
Figure 33: Global NGS Informatics Market (NGS Informatics Services), $Million, 2021-2032
Figure 34: Global NGS Informatics Market (by Application)
Figure 35: Global NGS Informatics Market, Incremental Opportunity (by Application), $Million, 2022-2032
Figure 36: Global NGS Informatics Market, Application of NGS in Drug Discovery
Figure 37: Global NGS Informatics Market (Drug Discovery), $Million, 2021-2032
Figure 38: Global NGS Informatics Market (Genetic Screening), $Million, 2021-2032
Figure 39: Global NGS Informatics Market (Disease Diagnosis), $Million, 2021-2032
Figure 40: Global NGS Informatics Market (Others), $Million, 2021-2032
Figure 41: Global NGS Informatics Market (by End User)
Figure 42: Global NGS Informatics Market, Incremental Opportunity (by End User), $Million, 2022-2032
Figure 43: Global NGS Informatics Market (Hospitals and Clinics), $Million, 2021-2032
Figure 44: Global NGS Informatics Market (Pharmaceutical and Biotechnology Companies), $Million, 2021-2032
Figure 45: Global NGS Informatics Market (Academic and Research Institutions), $Million, 2021-2032
Figure 46: Global NGS Informatics Market (by Region), 2022 and 2032
Figure 47: North America NGS Informatics Market, Incremental Opportunity (by Country), $Million, 2022-2032
Figure 48: North America NGS Informatics Market, $Million, 2021-2032
Figure 49: North America NGS Informatics Market (by End User), $Million, 2021-2032
Figure 50: North America NGS Informatics Market (by Country), $Million, 2022 and 2032
Figure 51: U.S. NGS Informatics Market, $Million, 2021-2032
Figure 52: U.S. NGS Informatics Market (by End User), $Million, 2021-2032
Figure 53: Canada NGS Informatics Market, $Million, 2021-2032
Figure 54: Canada NGS Informatics Market (by End User), $Million, 2021-2032
Figure 55: Europe NGS Informatics Market, Incremental Opportunity (by Country), $Million, 2022-2032
Figure 56: Europe NGS Informatics Market, $Million, 2021-2032
Figure 57: Europe NGS Informatics Market (by End User), $Million, 2021-2032
Figure 58: Europe NGS Informatics Market (by Country), % Share, 2022 and 2032
Figure 59: Germany NGS Informatics Market, $Million, 2021-2032
Figure 60: Germany NGS Informatics Market (by End User), $Million, 2021-2032
Figure 61: France NGS Informatics Market, $Million, 2021-2032
Figure 62: France NGS Informatics Market (by End User), $Million, 2021-2032
Figure 63: U.K. NGS Informatics Market, $Million, 2021-2032
Figure 64: U.K. NGS Informatics Market (by End User), $Million, 2021-2032
Figure 65: Italy NGS Informatics Market, $Million, 2021-2032
Figure 66: Italy NGS Informatics Market (by End User), $Million, 2021-2032
Figure 67: Spain NGS Informatics Market, $Million, 2021-2032
Figure 68: Spain NGS Informatics Market (by End User), $Million, 2021-2032
Figure 69: Rest-of-Europe NGS Informatics Market, $Million, 2021-2032
Figure 70: Rest-of-Europe NGS Informatics Market (by End User), $Million, 2021-2032
Figure 71: Asia-Pacific NGS Informatics Market Incremental Opportunity (by Country), $Million, 2022-2032
Figure 72: Asia-Pacific NGS Informatics Market, $Million, 2021-2032
Figure 73: Asia-Pacific NGS Informatics Market (by End User), $Million, 2021-2032
Figure 74: Asia-Pacific NGS Informatics Market (by Country), Share %, 2022 and 2032
Figure 75: China NGS Informatics Market, $Million, 2021-2032
Figure 76: China NGS Informatics Market (by End User), $Million, 2021-2032
Figure 77: Japan NGS Informatics Market, $Million, 2021-2032
Figure 78: Japan NGS Informatics Market (by End User), $Million, 2021-2032
Figure 79: India NGS Informatics Market, $Million, 2021-2032
Figure 80: India NGS Informatics Market (by End User), $Million, 2021-2032
Figure 81: Australia NGS Informatics Market, $Million, 2021-2032
Figure 82: Australia NGS Informatics Market (by End User), $Million, 2021-2032
Figure 83: South Korea NGS Informatics Market, $Million, 2021-2032
Figure 84: South Korea NGS Informatics Market (by End User), $Million, 2021-2032
Figure 85: Rest-of-Asia-Pacific NGS Informatics Market, $Million, 2021-2032
Figure 86: Rest-of-Asia-Pacific NGS Informatics Market (by End User), $Million, 2021-2032
Figure 87: Latin America NGS Informatics Market Incremental Opportunity (by Country), $Million, 2022-2032
Figure 88: Latin America NGS Informatics Market, $Million, 2021-2032
Figure 89: Latin America NGS Informatics Market (by End User), $Million, 2021-2032
Figure 90: Latin America NGS Informatics Market (by Country), $Million, 2022 and 2032
Figure 91: Brazil NGS Informatics Market, $Million, 2021-2032
Figure 92: Brazil NGS Informatics Market (by End User), $Million, 2021-2032
Figure 93: Mexico NGS Informatics Market, $Million, 2021-2032
Figure 94: Mexico NGS Informatics Market (by End User), $Million, 2021-2032
Figure 95: Rest-of-Latin America NGS Informatics Market, $Million, 2021-2032
Figure 96: Rest-of-Latin America NGS Informatics Market (by End User), $Million, 2021-2032
Figure 97: Rest-of-the-World NGS Informatics Market Incremental Opportunity (by Country), $Million, 2022-2032
Figure 98: Rest-of-the-World NGS Informatics Market, $Million, 2021-2032
Figure 99: Rest-of-the-World NGS Informatics Market (by End User), $Million, 2021-2032
Figure 100: Share of Key Developments and Strategies, January 2018-October 2022
Figure 101: New Offerings (by Company), January 2018-October 2022
Figure 102: Mergers and Acquisitions (by Company), January 2018-October 2022
Figure 103: Partnerships, Alliances, and Business Expansions (by Company), January 2018-October 2022
Figure 104: Regulatory and Legal Activities (by Company), January 2018-October 2022
Figure 105: Funding Activities (by Company), January 2018-October 2022
Figure 106: Global NGS Informatics Market, Growth-Share Matrix (by Products and Services), 2022-2032
Figure 107: Global NGS Informatics Market, Growth-Share Matrix (by Application), 2022-2032
Figure 108: Global NGS Informatics Market, Growth-Share Matrix (by End User), 2022-2032
Figure 109: Abbott Laboratories: Product Portfolio
Figure 110: Abbott Laboratories: Overall Financials, $Million, 2019-2021
Figure 111: Abbott Laboratories: Segment Revenues, $Million, 2019-2021
Figure 112: Abbott Laboratories: Net Revenue (by Region), $Million, 2019-2021
Figure 113: Abbott Laboratories: R&D Expenditure, $Million, 2019-2021
Figure 114: Agilent Technologies, Inc.: Product Portfolio
Figure 115: Agilent Technologies, Inc.: Overall Financials, $Million, 2019-2021
Figure 116: Agilent Technologies, Inc.: Segment Revenues, $Million, 2019-2021
Figure 117: Agilent Technologies, Inc.: Net Revenue (by Region), $Million, 2019-2021
Figure 118: Agilent Technologies, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 119: Azenta, Inc.: Product Portfolio
Figure 120: Azenta, Inc.: Overall Financials, $Million, 2020-2022
Figure 121: Azenta, Inc.: Segment Revenue, $Million, 2020-2022
Figure 122: Azenta, Inc.: Net Revenue (by Region), $Million, 2020-2022
Figure 123: Azenta, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 124: BGI Genomics Co., Ltd. Product Portfolio
Figure 125: BGI Genomics Co., Ltd.: Overall Financials, $Million, 2018-2020
Figure 126: DNAnexus, Inc.: Product Portfolio
Figure 127: Eagle Genomics: Product Portfolio
Figure 128: Euformatics: Product Portfolio
Figure 129: F. Hoffmann-La Roche Ltd.: Product Portfolio
Figure 130: F. Hoffmann-La Roche Ltd.: Overall Financials, $Million, 2019-2021
Figure 131: F. Hoffmann-La Roche Ltd.: Segment Revenues, $Million, 2019-2021
Figure 132: F. Hoffmann-La Roche Ltd.: Net Revenue (by Region), $Million, 2019-2021
Figure 133: F. Hoffmann-La Roche Ltd.: R&D Expenditure, $Million, 2019-2021
Figure 134: Genalice BV: Product Portfolio
Figure 135: Illumina, Inc.: Product Portfolio
Figure 136: Illumina, Inc.: Overall Financials, $Million, 2019-2021
Figure 137: Illumina, Inc.: Segment Revenues, $Million, 2021
Figure 138: Illumina, Inc.: Segment Revenues, $Million, 2019-2020
Figure 139: Illumina, Inc.: Net Revenue (by Region), $Million, 2019-2021
Figure 140: Illumina, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 141: Partek Incorporated: Product Portfolio
Figure 142: PerkinElmer, Inc.: Product Portfolio
Figure 143: PerkinElmer, Inc.: Overall Financials, $Million, 2019-2021
Figure 144: PerkinElmer, Inc.: Segment Revenues, $Million, 2019-2021
Figure 145: PerkinElmer, Inc.: Net Revenue (by Region), $Million 2019-2021
Figure 146: PerkinElmer, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 147: Precigen, Inc.: Product Portfolio
Figure 148: Precigen, Inc.: Overall Financials, $Million, 2019-2021
Figure 149: Precigen, Inc.: Segment Revenues, $Million, 2019-2021
Figure 150: Precigen, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 151: QIAGEN N.V.: Product Portfolio
Figure 152: QIAGEN N.V.: Overall Financials, $Million, 2019-2021
Figure 153: QIAGEN N.V.: Segment Revenues, $Million, 2019-2021
Figure 154: QIAGEN N.V.: Net Revenue (by Region), $Million, 2019-2021
Figure 155: QIAGEN N.V.: R&D Expenditure, $Million, 2019-2021
Figure 156: SOPHiA GENETICS SA: Product Portfolio
Figure 157: SOPHiA GENETICS SA: Overall Financials, $Million, 2019-2021
Figure 158: SOPHiA GENETICS SA: Segment Revenues, $Million, 2019-2021
Figure 159: SOPHiA GENETICS SA: R&D Expenditure, $Million, 2019-2021
Figure 160: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 161: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2019-2021
Figure 162: Thermo Fisher Scientific Inc.: Segment Revenues, $Million, 2019-2021
Figure 163: Thermo Fisher Scientific Inc.: Net Revenue (by Region), $Million, 2019-2021
Figure 164: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2019-2021
List of Tables
Table 1: Global NGS Informatics Market, Quarterly Key Developments Analysis, January 2018-October 2022
Table 2: Key Questions Answered in the Report
Table 3: List of Regulatory Authorities
Table 4: Global NGS Informatics Market, Product Benchmarking
Table 5: Costs (in $) of NGS Applications
Table 6: Global NGS Informatics Market, NGS Tests Developed for the SARS-CoV-2 Virus
Table 7: Global NGS Informatics Market, Volume of Data Generated for Common NGS Applications
Table 8: North America NGS Informatics Market, Impact Analysis
Table 9: Europe NGS Informatics Market, Impact Analysis
Table 10: Asia-Pacific NGS Informatics Market, Impact Analysis
Table 11: Latin America NGS Informatics Market, Impact Analysis
Table 12: Rest-of-the-World NGS Informatics Market, Impact Analysis

Companies Mentioned

Abbott Laboratories
Agilent Technologies, Inc.
Azenta, Inc.
BGI Genomics Co., Ltd.
DNAnexus, Inc.
Eagle Genomics
Euformatics
F. Hoffmann-La Roche Ltd
Genalice BV
Illumina, Inc.
Partek Incorporated
PerkinElmer, Inc.
Precigen, Inc.
QIAGEN N.V.
SOPHiA GENETICS SA
Thermo Fisher Scientific Inc.

Reviews

There are no reviews yet.

Be the first to review “NGS Informatics Market – A Global and Regional Analysis: Focus on Products and Services, Application, End User, and Region – Analysis and Forecast, 2022-2032”

Page Contents